UPDATE: Class 4 Medicines Defect Information: Atnahs Pharma UK Limited, Naprosyn Tablets (all strengths), Naprosyn EC 250mg Gastro-Resistant Tablets, Naprosyn EC 500mg Gastro-Resistant Tablets, EL (22)A/09

Source: MHRA Gov.uk 28.2.22

Atnahs Pharma UK Limited have identified additional missing information on the PIL of the certain product batches.

MDR Number

MDR 005-01/22

Company name

Atnahs Pharma UK Limited

Product description

  • Naprosyn 250mg Tablets PL 43252/0004
  • Naprosyn 500mg Tablets PL 43252/0005
  • Naprosyn EC 250mg Gastro-Resistant Tablets PL 43252/0006
  • Naprosyn EC 500mg Gastro-Resistant Tablets PL 43252/0008
Product Name Batch Number Pack Size Expiry Date First Distributed
Naprosyn 250mg Tablets E0098E5 56 tablets Feb-24 Jul-19
Naprosyn 250mg Tablets E0098E6 56 tablets Feb-24 Oct-19
Naprosyn 250mg Tablets E0102E1 56 tablets Jul-24 Nov-19
Naprosyn 250mg Tablets E0102E2 56 tablets Jul-24 Feb-20
Naprosyn 250mg Tablets E0103E1 56 tablets Sep-24 Feb-20
**Naprosyn EC 250mg Gastro-Resistant Tablets E0174E2 56 tablets Feb-22 Dec-19
**Naprosyn EC 250mg Gastro-Resistant Tablets E0183E1 56 tablets Apr-22 Apr-20
**Naprosyn EC 250mg Gastro-Resistant Tablets E0186E2 56 tablets Mar-22 Aug-20
**Naprosyn EC 250mg Gastro-Resistant Tablets E0187E1 56 tablets Mar-22 Oct-20
**Naprosyn EC 250mg Gastro-Resistant Tablets E0188E1 56 tablets Mar-22 Jul-21
**Naprosyn EC 250mg Gastro-Resistant Tablets E0188E4 56 tablets Mar-22 Aug-21
**Naprosyn EC 250mg Gastro-Resistant Tablets E0189E2 56 tablets Mar-22 Nov-20
**Naprosyn EC 250mg Gastro-Resistant Tablets E0190E1 56 tablets Mar-22 Nov-19
**Naprosyn EC 250mg Gastro-Resistant Tablets. E0191E1 56 tablets Mar-24 Aug-20
Naprosyn 500mg Tablets E0962E1 56 tablets Apr-24 Aug-20
Naprosyn 500mg Tablets E0963E1 56 tablets Apr-24 Sep-20
Naprosyn 500mg Tablets E0964E1 56 tablets Apr-23 Apr-19
Naprosyn 500mg Tablets E0965E2 56 tablets Apr-23 Jul-19
Naprosyn 500mg Tablets E0972E1 56 tablets Apr-24 Aug-20
Naprosyn 500mg Tablets E0973E1 56 tablets Apr-24 Sep-20
Naprosyn 500mg Tablets E0974E1 56 tablets Apr-24 Oct-19
Naprosyn 500mg Tablets E0975E1 56 tablets Apr-24 Nov-21
Naprosyn EC 500mg Gastro-Resistant Tablets E0596E1 56 tablets Mar-22 Nov-19
Naprosyn EC 500mg Gastro-Resistant Tablets E0601E1 56 tablets Apr-22 May-20
Naprosyn EC 500mg Gastro-Resistant Tablets E0601E4 56 tablets Apr-22 Aug-20
Naprosyn EC 500mg Gastro-Resistant Tablets E0615E1 56 tablets Apr-22 Aug-20
Naprosyn EC 500mg Gastro-Resistant Tablets E0622E1 56 tablets Jun-22 Feb-20
Naprosyn EC 500mg Gastro-Resistant Tablets E0623E1 56 tablets Jun-22 Feb-20
Naprosyn EC 500mg Gastro-Resistant Tablets E0626E1 56 tablets Jun-22 Jul-20
Naprosyn EC 500mg Gastro-Resistant Tablets E0627E1 56 tablets Jun-22 Nov-20
Naprosyn EC 500mg Gastro-Resistant Tablets E0628E1 56 tablets Jun-22 Mar-20
Naprosyn EC 500mg Gastro-Resistant Tablets E0628E2 56 tablets Jun-22 Mar-20
Naprosyn EC 500mg Gastro-Resistant Tablets E0632E3 56 tablets Jul-22 Mar-20
Naprosyn EC 500mg Gastro-Resistant Tablets E0633E2 56 tablets Jul-22 Mar-20
Naprosyn EC 500mg Gastro-Resistant Tablets E0634E3 56 tablets Jul-22 Mar-20
Naprosyn EC 500mg Gastro-Resistant Tablets E0635E2 56 tablets Jul-22 Mar-20
Naprosyn EC 500mg Gastro-Resistant Tablets E0636E1 56 tablets Jul-22 Mar-20
Naprosyn EC 500mg Gastro-Resistant Tablets E0637E1 56 tablets Jul-22 Mar-20
Naprosyn EC 500mg Gastro-Resistant Tablets E0640E2 56 tablets Jul-22 Mar-20
Naprosyn EC 500mg Gastro-Resistant Tablets E0656E1 56 tablets Aug-22 Nov-20
Naprosyn EC 500mg Gastro-Resistant Tablets E0657E1 56 tablets Aug-22 Feb-22
Naprosyn EC 500mg Gastro-Resistant Tablets E0658E1 56 tablets Sep-22 Jan-22
Naprosyn EC 500mg Gastro-Resistant Tablets E0665E1 56 tablets Sep-22 Oct-21
Naprosyn EC 500mg Gastro-Resistant Tablets E0666E1 56 tablets Sep-22 Oct-21

Active Pharmaceutical Ingredient: naproxen

**Following correction by Atnahs Pharma UK Limited, an update was made on 28 February 2022 to reflect correction of product name and expiry dates.

Brief description of the problem

Additional to the batches included in the previous Class 4 Medicines Notification (reference EL(22)A/05), Atnahs Pharma UK Limited have informed us that the Patient Information Leaflets (PILs) in the above batches are missing the following information (in bold):

Section 2: Other medicines and Naprosyn Tablets

Talk to your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. This includes medicines that you buy without a prescription and herbal medicines. In particular tell you doctor or pharmacist if you are taking:

Medicine to stop your blood clotting, like aspirin/acetylsalicylic acid, warfarin, heparin or clopidogrel

Advice for healthcare professionals

There is no risk to the product quality as a result of this issue, therefore these affected batches are not being recalled.

Healthcare professionals are advised to exercise caution when dispensing this product. Please check the Marketing Authorisation Holder and the batch number; if any of the above batch numbers are being dispensed, please provide an updated PIL. The updated PILs are available via the electronic Medicines Compendium website:

Healthcare professionals should also remind patients to seek medical advice if taking aspirin/acetylsalicylic acid with Naprosyn Tablets or Naprosyn EC Gastro-Resistant Tablets, due to the increased risk of bleeding when these medicines are taken concurrently. Patients who experience adverse reactions should seek immediate medical attention. Any suspected adverse reactions should be reported via the MHRA Yellow Card scheme

Atnahs Pharma UK Limited have confirmed that all other batches of Naprosyn Tablets and Naprosyn EC Gastro-Resistant Tablets contain the correct PILs. Hard copies of the updated PIL could be provided by the MAH upon request, so that any affected batch remaining in the dispensary can be supplemented with the updated PIL.

Further Information

For more information, medical information queries or stock control queries, please contact: info@pharmanovia.com.

Recipients of this Medicines Notification should bring it to the attention of relevant contacts by copy of this notice. NHS regional teams are asked to forward this to community pharmacists and dispensing general practitioners for information.

Yours faithfully

Defective Medicines Report Centre
10 South Colonnade
Canary Wharf
London
E14 4PU
Telephone +44 (0)20 3080 6574

Download document

Class 4 Medicines Defect Information: Atnahs Pharma UK Limited, Naprosyn Tablets (all strengths), Naprosyn EC 500mg Gastro-Resistant Tablets, EL (22)A/09

Please click here for the source